A Canadian company founded in 2002, Prollenium Medical Technologies develops cutting edge products in the medical devices industry. Our focus on aesthetics and our fully integrated approach to development and production enables us to create products that reflect a true understanding of the market and real-world applications.
Prollenium’s paramount product, Revanesse, is a line of cross-linked hyaluronic acid (HA) dermal fillers – a true example of our attention to detail and end-to-end capabilities. Revanesse is developed, manufactured and distributed by Prollenium in Ontario, Canada. We accredit Revanesse’s success to our commitment to quality, attention to detail, world-class manufacturing standards and hands-on oversight. Today, Revanesse can be found in over 80 countries worldwide.
Product development and advancement is a top priority as Prollenium remains committed to the belief that its providers and patients deserve the best.
Prollenium Medical is committed to product excellence and is proud to be a registered ISO 13485:2003 company. Prollenium is an FDA Approved Facility.